Son of Sevenless Homolog 1 (SOS1) Gene Mutation Analysis
Son of sevenless homolog 1 (SOS1) gene is located at 2p22.1 encodes a protein that is involved in regulating the activation of the RAS/MAPK signaling pathway by promoting the conversion of GTP to GDP. The RAS/MAPK pathway is responsible for controlled cellular growth, proliferation, division, and apoptosis. The continuous switching on and off of the RAS/MAPK pathway is controlled by SOS1 protein. Mutations of with SOS1 gene, may result in prolonged activation of the signaling pathway and is associated in Noonan syndrome type 4.
Noonan syndrome (NS) is a developmental disorder characterized by short stature, craniofacial dysmorphisms, and congenital heart defects (CHD), in particular pulmonary valve stenosis (PVS). Other signs and symptoms include a broad or webbed neck, an atypical chest shape with superior and inferior pectus carinatum, cryptorchidism, various coagulation disorders, lymphatic dysplasia, and ocular abnormalities. NS affects between 1 in 1000 and 1 in 2500 live births. Although length at birth is generally normal, the final adult height is usually below the normal range.
The diagnosis of Noonan syndrome is established in a proband with suggestive findings and a heterozygous pathogenic variant in BRAF, KRAS, MAP2K1, MRAS, NRAS, PTPN11, RAF1, RASA2, RIT1, RRAS2, SOS1, or SOS2 or either a heterozygous variant or biallelic pathogenic variants in LZTR1 identified by molecular genetic testing.
SOS1 is part of gene mutation panels used for diagnosis of cardiomyopathies and Turner syndrome.
- As an aid in the diagnosis of Noonan syndrome
- Screening neonates for susceptibility to Noonan syndrome
A positive result indicates the presence of mutations or pathogenic variants in the SOS1 gene, thus suggesting Noonan syndrome or its susceptibility.
A negative result indicates the absence of mutations or pathogenic variants detected in the SOS1 gene. However, other genes BRAF, KRAS, MAP2K1, MRAS, NRAS, PTPN11, RAF1, RASA2, RIT1, and RRAS2 should also be analyzed prior to ruling out the diagnosis.
Negative for mutations analyzed (No mutation or pathogenic variant detected)
Whole blood collected in EDTA (lavender top tube).
Stability
- Room: 3-5 days
- Refrigerated: 7-14 days
- Frozen: unstable
- J Hum Genet. 2008;53(9):834-841. [PMID: 18651097]
- Curr Opin Endocrinol Diabetes Obes. 2012 Feb;19(1):40-6. [PMID: 22157403]
- Eur J Hum Genet. 2004 Dec;12(12):1069-72. [PMID: 15470362]
- Lancet. 2013 Jan 26;381(9863):333-42. [PMID: 23312968]